Increasing studies have already indicated that KAT2A was an epigenetic oncogene in various cancers, like pancreatic carcinoma, gastric carcinogenesis, and nasopharyngeal carcinoma (Sun et al., 2016; Bondy-Chorney et al., 2019; Wang et al., 2020). Here, KAT2A is linked to nasopharyngeal carcinoma.